Branca Bunús

Branca Bunús is a UCD start-up gene therapy company. Branca Bunús is committed to the development and commercialization of gene therapy products for the treatment of patients with genetic diseases worldwide. Our patented gene therapy platform technology focuses on a non-viral polymer-based delivery method. Our initial focus is on developing CRISPR gene-editing therapies using our unique non-viral polymer platform technology to treat the rare skin disease recessive dystrophic epidermolysis bullosa (RDEB).